Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,082,110
Closed -$30.3M 47
2024
Q2
$30.3M Sell
1,082,110
-162,134
-13% -$4.46M 26.17% 1
2024
Q1
$34.5M Sell
1,244,244
-3,704
-0.3% -$103K 31.13% 1
2023
Q4
$35.9M Sell
1,247,948
-45,105
-3% -$1.36M 35.41% 1
2023
Q3
$42.9M Sell
1,293,053
-780
-0.1% -$27.6K 43.37% 1
2023
Q2
$47.5M Sell
1,293,833
-3,423
-0.3% -$133K 45.13% 1
2023
Q1
$52.9M Hold
1,297,256
49.77% 1
2022
Q4
$66.5M Sell
1,297,256
-348
-0% -$16.7K 56.76% 1
2022
Q3
$56.8M Buy
+1,297,604
New +$63.1M 53.44% 1
2022
Q1
$67.2M Hold
1,297,604
51.73% 1
2021
Q4
$76.6M Sell
1,297,604
-23,727
-2% -$1.18M 54.4% 1
2021
Q3
$56.8M Sell
1,321,331
-213,529
-14% -$9.46M 44.74% 1
2021
Q2
$60.1M Sell
1,534,860
-299,347
-16% -$11.6M 46.32% 1
2021
Q1
$66.5M Sell
1,834,207
-10,082
-0.5% -$358K 54.51% 1
2020
Q4
$67.9M Buy
1,844,289
+1,815,933
+6,404% +$66.6M 22.99% 1
2020
Q3
$733K Sell
28,356
-101,088
-78% -$3.54M 0.31% 47
2020
Q2
$4.02M Buy
129,444
+118,322
+1,064% +$4.02M 2.06% 8
2020
Q1
$344K Hold
11,122
0.22% 38
2019
Q4
$413K Buy
+11,122
New +$396K 0.26% 36

Other funds holding PFE

Stevard LLC's PFE Position: Q3 2024 in Review

Stevard LLC sold out of Pfizer (PFE) in Q3 2024, closing a stake of 1,082,110 shares — an estimated $30.3M sold.

Stevard LLC first reported a position in PFE in Q4 2019 and held it in 18 quarters. The position peaked at $76.6M in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Stevard LLC reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • Stevard LLC sold 1,082,110 Pfizer shares in Q3 2024, an estimated $30.3M.
  • Stevard LLC first reported a position in Pfizer in Q4 2019 and held it in 18 quarters.
  • Stevard LLC's Pfizer position peaked at $76.6M in Q4 2021.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Stevard LLC's 13F filing for Q3 2024, filed 14 Nov 2024.